Mirum Pharmaceuticals (MIRM) Q1 2023 Earnings

4MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.15
-1.03
-0.92
-0.8

Details

Expected EPS
-0.94
Actual EPS
-0.8
Surprise EPS
0.14
Surprise Percent
+14.89%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.8 per share for Q1 2023.

0 Comments

Share your thoughts